Correspondence Nicola Specchio, Division of Neurology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Email: nicola.specchio@opbg.net Summary Objective: PCDH19-related epilepsy is an epileptic syndrome with infantile onset, characterized by clustered and fever-induced seizures, often associated with intellectual disability (ID) and autistic features. The aim of this study was to analyze a large cohort of patients with PCDH19-related epilepsy and better define the epileptic phenotype, genotype-phenotype correlations, and related outcome-predicting factors. Methods: We retrospectively collected genetic, clinical, and electroencephalogram (EEG) data of 61 patients with PCDH19-related epilepsy followed at 15 epilepsy centers. All consecutively performed EEGs were analyzed, totaling 551. We considered as outcome measures the development of ID, autistic spectrum disorder (ASD), and seizure persistence. The analyzed variables were the following: gender, age at onset, age at study, genetic variant, fever sensitivity, seizure type, cluster occurrence, status epilepticus, EEG abnormalities, and cognitive and behavioral disorders. Receiver operating characteristic curve analysis was performed to evaluate the age at which seizures might decrease in frequency. Results: At last follow-up (median = 12 years, range = 1.9-42.1 years), 48 patients (78.7%) had annual seizures/clusters, 13 patients (21.3%) had monthly to weekly seizures, and 12 patients (19.7%) were seizure-free for ≥2 years. Receiver operating characteristic analysis showed a significant decrease of seizure frequency after the age of 10.5 years (sensitivity = 81.0%, specificity = 70.0%).
Thirty-six patients (59.0%) had ID and behavioral disturbances. ASD was present in 31 patients. An earlier age at epilepsy onset emerged as the only predictive factor for ID (P = 0.047) and ASD (P = 0.014). Conversely, age at onset was not a predictive factor for seizure outcome (P = 0.124). Significance: We found that earlier age at epilepsy onset is related to a significant risk for ID and ASD. Furthermore, long-term follow-up showed that after the age of 10 years, seizures decrease in frequency and cognitive and behavioral disturbances remain the primary clinical problems.
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| INTRODUCTION
PCDH19-related epilepsy is an epileptic syndrome, with onset around the first year of life, characterized by mostly clustered and fever-induced seizures. The first association between PCDH19 gene mutations and epilepsy dates back to 2008. 1, 2 Since then, the number of patients with PCDH19-related epilepsy has grown and a more detailed phenotype has been delineated. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] PCDH19 is currently regarded as one of the most frequently mutated genes in epilepsy following SCN1A, but estimates of incidence and prevalence are lacking. Studies of large cohorts of females show rates of PCDH19 mutations ranging from 2% to 20% depending on the phenotype of the analyzed patients. 10, 14 Although the PCDH19 gene is located on Xq22, this condition has an unusual X-linked mode of inheritance
Key Points
• Earlier age at epilepsy onset was the only predicting factor for intellectual disability and autism spectrum disorder • After the age of 10 years, seizures decrease in frequency and cognitive and behavioral disturbances become the most relevant symptoms • Seizures have motor or nonmotor semiology; fearful expression was reported as one of the most common initial ictal manifestations • Genotype-phenotype correlations remain elusive considering the site and type of PCDH19 genetic variants sparing transmitting males, who are affected only when somatic mosaicism for the PCDH19 mutation occurs. 3, [10] [11] [12] [13] Epilepsy is characterized by predominantly focal seizures, induced by fever and recurring in clusters, lasting hours to days. Generalized seizures (tonic, myoclonic, and absence) are reported in a minority of patients. The occurrence of focal seizures primarily with affective symptoms emerged as a hallmark of this syndrome. 8 The electroencephalographic (EEG) features are still poorly defined. Interictal EEG is highly variable; it is reported to be normal in approximately half of patients or characterized by slowing of background activity and epileptiform and/or slow wave abnormalities in the remaining. 8 In most patients, epilepsy is associated with intellectual disability (ID) and autistic spectrum disorder (ASD), but patients with normal psychomotor development have also been reported. 3, 8 Based on current knowledge, the clinical phenotype is highly variable, ranging from well-controlled epilepsy with normal cognitive development to drug-resistant epilepsy with severe ID, 1,3-5,7-9 and genotype-phenotype correlations are not yet feasible.
We collected a large cohort of patients in this study with the aim of better defining the epilepsy phenotype and clarifying aspects of genotype-phenotype correlations and outcome predictors that are still unclear.
| MATERIALS AND METHODS
This is a retrospective multicenter study. We collected 61 patients with PCDH19-related epilepsy, followed in 15 Italian epilepsy centers.
We evaluated (1) phenotype and correlation with genetic variants, (2) EEGs, and (3) prognostic factors.
For each patient, the referring physician filled out a detailed clinical questionnaire including neurologic and neuropsychological assessments, seizure semiology and frequency, brain imaging, and genetic variant.
All available EEGs (n = 551) were analyzed. We collected data on parameters of recording, vigilance status, background activity, presence, type, and localization of epileptiform and slow wave abnormalities, presence of photoparoxysmal response, and electroclinical characteristics of recorded seizures. When an actual EEG recording was unavailable (52.2%), analysis was based on EEG reports.
Informed consent for clinical data and video-EEG studies was obtained for all patients in each participating institution from parents or legal guardians. This cohort also includes previously reported patients. 7, 9, 10, 15, 16 Epileptic seizures were classified according to the International League Against Epilepsy criteria. 17 We considered as outcome measures the development of ID, ASD, and seizure persistence. Moreover, we considered the global outcome, stratifying patients into two groups: (1) patients with normal cognitive development who had been seizure-free for at least 2 years at last follow-up, and (2) patients with cognitive delay and active seizures. The analyzed variables were as follows: gender, age at onset, age at time of the study, type of genetic variant, fever sensitivity, seizure type, cluster occurrence, status epilepticus (SE) occurrence, presence of EEG abnormalities, and cognitive and behavioral disorders. Fever sensitivity has been defined as the occurrence of at least one seizure during fever. Genetic variants were grouped according to type of mutation (missense, splicing, nonsense, frameshift/rearrangements) and exon location (exon 1, exon 2, exon 3-6). Outcome measures for genotype-phenotype correlation were the same as for the other prognostic factors.
| Statistical analysis
Statistical analysis was performed using R version 3.2.3 (R Foundation for Statistical Computing, http://www.Rproject.org/). Prior to modeling, the data were summarized with descriptive statistics for each variable, including means, medians, and range for continuous variables and frequencies for categorical variables. An independent t test and the Mann-Whitney U test with continuity correction were used for continuous variables; analysis of variance was used for the comparison of the mean of multiple groups with Tukey honest significant difference post hoc analysis when necessary. For dichotomous results, a chisquare test or the Fisher's exact test was performed, as appropriate.
A P value < 0.05 was considered to indicate statistical significance. All statistical tests were two-tailed. Receiver operating characteristic curve analysis was performed to discriminate the age at which seizures start to decrease in frequency.
| RESULTS

| Clinical features
Median age at study was 12.0 years (95% confidence interval [CI] = 7.4-16.0 years, range = 1.9-42.1 years). Two of 61 enrolled patients (3.3%) were males with a PCDH19 gene variant in mosaic status (already stated). We collected 15 patients with familial distribution, 11 inherited, and two pairs of twins with de novo genetic variants. Clinical and genetic details of all patients are included in Table S1 .
The median age at epilepsy onset was 10.0 months (95% CI = 7.0-16.0 months, range = 1.0-68.0 months). The majority of patients had clustered seizures (n = 52, 85.4%) and/or fever sensitivity (n = 57, 93.4%). More than one seizure type was reported to have occurred in all patients, including, according to semiology, seizures with motor onset (85.2%) and without motor onset (59.0%). Motor seizures were primarily tonic. Nonmotor seizures were characterized by psychomotor arrest, loss of muscle tone, hypopnea, cyanosis, and desaturation. In 82.0% of patients, both motor and nonmotor seizures were accompanied by a fearful expression as one of the initial ictal manifestations. Generalized seizures were described in seven patients (11.4%), and they were reported as absence (9.8%) and/or myoclonic (4.9%). Atonic, generalized tonic-clonic seizures and spasms were neither recorded nor reported. Seizure frequency was highly variable, with multiple episodes in a few hours (seizure clusters) and long seizure-free periods lasting up to several years (8 years in two patients). In 19 patients (31.1%), seizure clusters resulted in SE; in seven patients (36.8%) SE was nonconvulsive, whereas in 12 patients (63.2%) it consisted of repetitive seizures with motor or nonmotor seizures occurring without consciousness being regained between episodes.
| EEG features
A mean number of 9.0 EEGs (range = 1-37) per patient were analyzed. The mean age at EEG recording was 6.2 years (range = 6 months to 38.3 years). In 135 EEGs (28.7%), a video recording was also available; in 177 EEGs (37.6%), a polygraphic recording was also available. In 14 patients, long-term monitoring was performed (mean = 14 hours). Mean EEG follow-up was 5.6 years (range = 0-37.4 years). Most EEGs (79.8%) were recorded during wakefulness.
| Interictal EEGs
Awake EEGs showed good organization and differentiation of background activity in 73.1%. The remaining recordings (26.9%) showed diffuse background slowing. Among sleep EEGs, only approximately half (49.5%) showed good sleep organization with physiological non-rapid eye movement patterns. Epileptiform abnormalities were detected in approximately two-thirds of patients (63.9%), both focal (79.4%) and diffuse (23.5%). Multifocal abnormalities were detected in 26.4% of all EEGs. None of our patients had only properly generalized abnormalities. The prevalence of abnormalities did not differ between wakefulness (24.2%) and sleep (19.7%) recordings. We observed a wide variability in abnormality localization during follow-up, and we failed to identify a specific EEG pattern in the evolution during follow-up in all patients. The presence of interictal EEG abnormalities did not correlate with ID (P = 0.176) or ASD (P = 1).
Slow wave abnormalities were found in 76.5% of patients, more frequently during sleep (63.0% sleep vs 54.4% awake). Slow wave abnormalities were focal in 85% of EEGs, mainly localized over the temporal (56.1%) and central (26.9%) regions.
Photic stimulation induced a photoparoxysmal response in six patients (9.8%), and was an age-related EEG feature that in five patients was evident from the age of 7 to 12.5 years and in one patient from 3.5 to 5 years. In one patient, a transient fixation-off sensitivity was found from 11.4 to 13.4 years of age. In about half of EEGs (51.2%), intermittent photic stimulation could not be performed because of poor patient collaboration.
| Ictal EEGs
A total of 125 ictal EEGs belonging to 34 patients have been analyzed. Seventy-four ictal recordings were visually analyzed, whereas in the remaining the evaluation was based on EEG reports. Sixty-one seizures were also videorecorded. Focal seizures arose mainly from temporal (82.8%), frontal (6.2%), parieto-occipital (6.2%), and central (4.7%) regions. Forty-nine seizures (39.2%) had diffuse onset. Seizures with diffuse onset were characterized by a bilateral ictal discharge consisting of a diffuse slow spike followed by low-voltage often asymmetric theta activity, followed by bilateral rhythmic fast activity increasing in voltage and decreasing in frequency. From a clinical point of view, these bilateral seizures could have either motor (Figure 1 ) or nonmotor (Figure 2 ) semiology. Although these two types of seizures (motor and nonmotor) were stereotyped, they were not associated with a specific EEG pattern. In 78.9% of seizures, a fearful expression or affective symptoms were noted. True generalized seizures were never recorded. Absence seizures were not characterized by typical generalized 3-Hz spike and wave complexes but had frontal onset with fast synchronization (Figure 3) . In approximately one-fifth (19.4%) of recorded seizures, interhemispheric asynchrony was found, resembling two independent seizures (Figure 4 ). In the same cluster, seizures could begin in either or both hemispheres ( Figure 5 ).
Mean seizure duration was 65.3 seconds (range = 5-200 seconds). We analyzed 14 clusters of seizures and 65 single seizures. A higher incidence of seizures during sleep was observed (71.2% of recorded seizures).
SE was recorded in seven subjects. Three individuals exhibited nonconvulsive SE characterized by diffuse high-amplitude delta wave activity intermingled with lowvoltage spikes ( Figure S1 ) clinically related to unresponsiveness, eye deviation, oral automatisms, and distal myoclonic jerks; in two patients, these features were associated with vegetative symptoms such as tachycardia and/or abnormal breathing. The remaining four patients had motor 
| Long-term outcome
At last follow-up (median age = 12 years, 95% CI = 7.40-16.0 years, range = 1.9-42.1 years), 13 patients (21.3%) had monthly to weekly seizures, and 48 patients (78.7%) had annual or less frequent seizures/clusters. Among them, 12 patients (19.7%) were seizure-free for ≥2 years. Receiver operating characteristic analysis showed a significant decrease of seizure frequency after the age of 10.5 years (sensitivity = 81.0%, specificity = 70.0%; Figure S2 ). At last follow-up, 36 patients (59.0%) had ID and behavioral disturbances, at times both co-occurring in a single patient. ID was moderate to severe in 21 patients. ASD was detected in 31 patients. An earlier age at epilepsy onset was the only predicting factor for ID (P = 0.047) and ASD (P = 0.014). Conversely, age at onset was not a predicting factor for seizure outcome (P = 0.214). The group of patients with the worst outcome (combining seizure persistence and cognitive delay at follow-up) exhibited an earlier age at epilepsy onset as the only predicting factor (P = 0.009; Table 1 ).
| Genotype-phenotype correlation
The genetic findings of the 61 patients are reported in Table S1 . Thirty-one (50%) individuals carried a missense variant. The remaining patients carried frameshift/rearrangements (31.1%, n = 19), nonsense variants (13.1%, n = 8), or splicing site variants (3.3% n = 2).
Most of the variants lay in exon 1 (88.5%, n = 54), encoding for the extracellular domain; six variants were in exons 3-6, encoding for the intracellular domain; none of the variants was in exon 2, encoding for the transmembrane domain. We identified no correlations between the type or location of the genomic variants and unfavorable outcome associated with seizure persistence, ID, and ASD at follow-up. Genotype also could not be related with any other clinical feature (ie, gender, age at onset, age at study, type of genetic variant, fever sensitivity, seizure type, cluster occurrence, and SE occurrence).
| DISCUSSION
In recent years, much effort has been focused on molecular genetic studies of PCDH19-related epilepsy, with the Table S1 ). The seizure was recorded at the age of 2 years 6 months. The epileptic discharge consists of a diffuse recruiting theta activity, prevalent over bilateral central and parietal regions and lasting 45 seconds. Seizure semiology is characterized by loss of contact, diffuse hypertonia, fixed gaze, and distal and asynchronous myoclonic jerks of limbs. Electromyographic channels show the contraction of the deltoid muscles and the presence of high-frequency asynchronous myoclonic jerks purpose of elucidating the pathogenic bases of this syndrome. 16, 18, 19 Multiple hypotheses have been considered for the pathogenesis, particularly the mechanisms of cellular interference 4 and allopregnanolone deficiency due to neurosteroid-metabolizing enzyme downregulation. 16, 18 Likewise, the phenotypic spectrum of patients with PCDH19 mutations has been expanded.
5,8,10
| Electroclinical phenotypes
PCDH19-related epilepsy was initially named "epilepsy and mental retardation limited to females" (EFMR), 1, 2 underlining ID and exclusive occurrence in females as the two main findings of this syndrome. Thereafter, additional clinical and genetic studies were published gathering hundreds of female patients and leading to phenotypic expansion and refinement. 3,5-13 ID turned out to be an inconsistent finding, as approximately 30% of previously published patients and those in our cohort had normal cognitive development at last follow-up. Affected males with PCDH19 mosaic mutations are also on record, making this condition no longer a female-restricted disorder. Thus, its original acronym EFMR seems not representative of all patients. Mosaic male patients have the same phenotype presented by female patients, as reported in literature, because they have the same hypothesized pathological mechanism of molecular interference. [10] [11] [12] Subsequent studies have highlighted that most patients have clusters of focal seizures triggered by fever, representing the electroclinical hallmark of this epileptic syndrome. 1, 3 The seizure semiology appears to be highly variable during disease history, with a prevalence of nonmotor seizures in the first years of the disorder. Through analysis of the recorded seizures, we highlighted that although focal onset is a constant feature, generalized seizures often happened when rapid generalization occurred. Seizures independently arising from both hemispheres, even during the same cluster, and seizures characterized by asynchronous and independent discharges on both hemispheres, are often observed in genetic epilepsies, and in some aspects resemble epilepsy with migrating seizures of infancy (Figure 4) . Table S1 ). The seizure was recorded at age 21 months. The epileptic discharge consists of a diffuse recruiting theta activity, prevalent over bilateral frontal and central regions and lasting 60 seconds. Seizure semiology is characterized by staring, slight and brief upper limb hypertonia (right > left), impairment of contact, hypopnea, desaturation (SO 2 = 42%), and lip cyanosis TRIVISANO ET AL.
In 40% of seizures, the EEGs showed bilateral discharge and many of them were difficult to classify as focal or generalized.
From a clinical point of view, we classified these as motor (tonic-vibratory) or nonmotor seizures with focal signs (ie, eye deviation, oral automatisms, and asymmetric limb hypertonus).
We could not identify a characteristic interictal EEG. Interictal EEGs during a cluster of seizures might be normal or show diffuse slowing of background activity and multifocal spikes, without common specific features. The prevalence of interictal epileptiform abnormalities over the frontal and temporal regions has been hypothesized to be due to the possible prominent expression of protocadherin 19 in the areas connected to the hippocampal formation, such as the entorhinal cortex, lateral septum, and basolateral amygdaloid complex, as has been demonstrated in rats. 20, 21 This finding is also supported by the temporal region onset of seizures and by the prevalence of affective symptoms during seizures, as reported by Marini et al in 2012 and also confirmed in this cohort. 8 Interictal EEG abnormalities were not detected in approximately one-third of patients during the entire follow-up period. This figure is lower than previously reported (48%-57%). 5, 8 Photoparoxysmal response has been described only in a few patients. 3, 4, 8, 9 We found transient photosensitivity in approximately 10% of patients. This can be considered a distinctive feature from Dravet syndrome, in which photoparoxysmal response is reported in approximately 64% of patients.
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Brain magnetic resonance imaging was normal in all patients, although recent studies have identified a possible role of protocadherin 19 in neuronal cortical migration and some brain magnetic resonance imaging abnormalities in mutated mice. 23 Recently, a small case series of patients with a PCDH19 gene mutation and focal cortical dysplasia was reported. 24 This is a novel finding that needs further studies with advanced brain magnetic resonance imaging technologies and histopathology to be better understood.
| Predicting factors and outcome
Although a few patients had a short follow-up period, most of the patients in our cohort had an adequate follow-up period (median = 12 years, 95% CI = 7.40-16.0 years) to provide original data. During the first decade, epilepsy tended to be active and resistant to multiple antiepileptic drugs (AEDs). Later on, we observed a decrease in seizures regardless of treatment. Receiver operating characteristic analysis showed that after 10.5 years, seizures started to decrease in frequency. This finding might support the hypothesis of allopregnanolone deficiency. 18 At the age of 10.5 years, hormonal changes for puberty start, and these Table S1 ). The seizure was recorded at age 14 years. The epileptic discharge consists of spike-andwave complexes at 4.5 Hz, prevalent over the frontal regions data might support the hypothesis of neurosteroid-metabolizing enzymes in PCDH19-related epilepsy. Recently, Tan et al summarized all available data regarding seizure onset and offset ages of all published females with PCDH19 mutation. The low frequency of seizures could be related to low steroid hormone levels between the so-called "minipuberty" (0-6 months) and after puberty. 18 At last follow-up, patients had a median of two AEDs. A recent study showed that the most effective drugs in patients with a PCDH19 mutation were bromide and clobazam. 25 Clobazam was widely used in our cohort, both in chronic administration and for acute treatment of clusters, whereas bromide was not. However, assessing the effectiveness of AEDs in this epileptic syndrome is difficult due to the highly variable seizure frequency and a possible agedependent spontaneous seizure reduction. The retrospective nature of this study does not allow any firm conclusions about efficacy of specific AEDs. Four patients (Patients 5, 6, 7, and 61) were treated with stiripentol associated with valproic acid and clobazam, and three of them (Patients 6, 7, and 61) experienced long-term remission (1-3 years).
In PCDH19-related epilepsy, a significant risk of ASD and ID might emerge during the second year of life, without significant risks for motor deterioration. [26] [27] [28] Motor development appears to be normal, in contrast to observations in patients with Dravet syndrome. At last follow-up, approximately two-thirds of patients developed ID and ASD, and the younger age at epilepsy onset was found to be a predictive factor. These findings were also recently reported in a wide revision study on 271 published mutated subjects 29 and might derive from a more severe expression of disease in patients with earlier age at onset, as they develop drug resistant-epilepsy, ID, and ASD, probably due to a combination of genetic and environmental factors such as early AED treatments and multiple hospitalizations. Interestingly, the severity of epilepsy did not correlate with a worse cognitive and behavioral outcome, meaning that these symptoms are due mainly to the underlying condition and not to epilepsy. Also, ID and ASD seemed to be independent, thus confirming that ASD could be a comorbidity rather than a consequence of ID. 29 After puberty, when seizures start to decrease in frequency, ID and ASD become Table S1 ). The ictal discharge starts from the right temporal region, with a rhythmic theta activity. Later it spreads to the same region of the contralateral hemisphere. The ictal discharge persists mainly over bilateral temporal regions and stops independently first on the right and later (after 25 seconds) on the left hemisphere. The seizure is characterized by fixed gaze, loss of contact, hypopnea, and cyanosis without clinical evident motor signs. Seizure duration is about 160 seconds. This seizure is part of a cluster that occurred at the age of 11 months (seizure onset) the most relevant symptoms. Therefore, a greater effort should be made in the future in identifying ASD and ID early in infancy to start a personalized rehabilitation program earlier.
The predicting factor of age at onset has already been reported for other epileptic syndromes, as recently for Dravet syndrome. 
| Genotype-phenotype correlations
We failed to identify any genotype-phenotype correlation regarding the site and type of PCDH19 variant. This result is reasonable considering that a cellular interference mechanism has been hypothesized for PCDH19-related epilepsy. Based on this hypothesis, seizures and ID result from a dysfunction of interaction between mixed (mutated and not-mutated) neuronal populations, independently from the type of genetic variant, but rather depending on the protein domain involved (ie, extracellular or intracellular). Therefore, even if the protein domain involved and the type of PCDH19 gene variant (ie, missense, splicing, nonsense, frameshift/rearrangements) are irrelevant for prognosis, the location of the genomic variants correlates with their pathogenicity, showing pathogenic variants mainly located in exon 1 (the extracellular domain). Skewed X-inactivation may play a greater role in females with a milder phenotype or in asymptomatic carriers as well as the hypothesis of a downregulation of neurosteroid-metabolizing enzymes and allopregnanolone deficiency. 17 Other genes or environmental factors may also be involved in the phenotypes associated with PCDH19 gene mutations. 18, 31, 32 Even in familiar patients, we detected a remarkable phenotypic variability, including in the two pairs of monozygotic twins. As an example, among three sisters (Patients 17, 18, and 19; Table S1 ), we found differences in cognitive outcome and epilepsy severity. Also, in such patients, only age at epilepsy onset was confirmed as a prognostic factor. In this study, we included only affected patients, not considering asymptomatic carrier mothers and asymptomatic mutated sisters, because we focused on the epilepsy phenotype. These subjects, asymptomatic for seizures, should probably be deeply tested, as in some of them mild psychiatric symptoms might occur (eg, anxiety, panic attacks, aggressive behavior).
Overall, our findings expand and refine the clinical and EEG phenotype of patients with PCDH19-related epilepsy and confirm that the hallmark of this disorder is the onset in infancy of clusters of febrile focal seizures whose semiology often points to frontal involvement. Despite such infantile seizures, approximately 30% of patients never develop ID or ASD. The disorder affects females, yet a few males with mosaic PCDH19 mutations are also on record. The most interesting and novel finding here is the statistical evidence that an early age at onset is a negative prognostic factor for ID and ASD. Furthermore, long-term follow-up shows that after the age of 10 years, seizures decrease in frequency and cognitive and behavioral disturbances become the primary clinical problems. Genotypephenotype correlations remain poorly defined. Further experimental evidence is needed to shed light on the underlying pathophysiology of PCDH19-related epilepsy that will improve management and treatment and define the natural history and prognostic factors for outcome in this variable epilepsy phenotype.
